1. Home
  2. CISO vs GBIO Comparison

CISO vs GBIO Comparison

Compare CISO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • GBIO
  • Stock Information
  • Founded
  • CISO 2015
  • GBIO 2016
  • Country
  • CISO United States
  • GBIO United States
  • Employees
  • CISO N/A
  • GBIO N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • GBIO Health Care
  • Exchange
  • CISO Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • CISO 31.4M
  • GBIO 29.2M
  • IPO Year
  • CISO N/A
  • GBIO 2020
  • Fundamental
  • Price
  • CISO $1.13
  • GBIO $0.52
  • Analyst Decision
  • CISO
  • GBIO Strong Buy
  • Analyst Count
  • CISO 0
  • GBIO 4
  • Target Price
  • CISO N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • CISO 1.0M
  • GBIO 1.8M
  • Earning Date
  • CISO 08-13-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • CISO N/A
  • GBIO N/A
  • EPS Growth
  • CISO N/A
  • GBIO N/A
  • EPS
  • CISO N/A
  • GBIO N/A
  • Revenue
  • CISO $29,887,603.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • CISO N/A
  • GBIO N/A
  • Revenue Next Year
  • CISO N/A
  • GBIO N/A
  • P/E Ratio
  • CISO N/A
  • GBIO N/A
  • Revenue Growth
  • CISO N/A
  • GBIO 146.47
  • 52 Week Low
  • CISO $0.26
  • GBIO $0.30
  • 52 Week High
  • CISO $3.84
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • CISO 51.97
  • GBIO 66.42
  • Support Level
  • CISO $0.97
  • GBIO $0.32
  • Resistance Level
  • CISO $1.24
  • GBIO $0.59
  • Average True Range (ATR)
  • CISO 0.08
  • GBIO 0.05
  • MACD
  • CISO -0.01
  • GBIO 0.02
  • Stochastic Oscillator
  • CISO 63.77
  • GBIO 76.34

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: